Cognex (CGNX) CEO Moschner sells 24,962 shares after exercising options
Rhea-AI Filing Summary
COGNEX CORP CEO & President Matthew Moschner reported option-related trades in COGNEX CORP common stock on August 11, 2026. He exercised 16,600 stock options and sold 24,962 shares of common stock in open-market transactions. The option exercises and related sales were effected under a pre-arranged Rule 10b5-1 trading plan. Moschner continues to hold substantial unexercised stock options and restricted stock units expiring between 2031 and 2036.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
26 txns
Insider
Moschner Matthew
Role
CEO & President
Sold
24,962 shs ($1.60M)
Approx. gross sale proceeds
$1.60M
Approx. exercise cost
$759K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F1, F3 | 4,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F4 | 7,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F5 | 4,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F1, F6 | 1,600 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,600 | $56.44 | $90K |
| Sale | Common Stock F1 | 1,600 | $65.36 | $105K |
| Exercise | Common Stock F1 | 4,000 | $51.49 | $206K |
| Sale | Common Stock F1 | 4,000 | $65.36 | $261K |
| Exercise | Common Stock F1 | 4,000 | $40.71 | $163K |
| Sale | Common Stock F1 | 4,000 | $63.6158 | $254K |
| Exercise | Common Stock F1 | 7,000 | $42.84 | $300K |
| Sale | Common Stock F1 | 7,000 | $63.6102 | $445K |
| Sale | Common Stock F2 | 8,362 | $63.621 | $532K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 680,680 shares (Direct);
Common Stock — 10,884 shares (Direct);
Restricted Stock Unit — 82,338 shares (Direct)
Footnotes (6)
- F1. These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2. These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F3. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018).
- F4. The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date.
- F5. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
- F6. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Key Figures
Shares sold: 24,962 shares
Options exercised: 16,600 shares
Representative sale price: $65.36 per share
+3 more
6 metrics
Shares sold
24,962 shares
Total Cognex common shares sold by Matthew Moschner on August 11, 2026
Options exercised
16,600 shares
Total underlying shares from non-qualified stock options exercised on August 11, 2026
Representative sale price
$65.36 per share
Open-market sale price for 1,600 Cognex common shares on August 11, 2026
Largest remaining option block
279,070 shares at $27.99
Non-qualified stock option for Cognex common stock expiring May 5, 2035
RSU holding (largest grant)
56,928 shares
Restricted Stock Units for Cognex common stock expiring February 17, 2029
Additional option exercise prices
$42.84, $51.49, $56.44
Exercise prices for other non-qualified stock options exercised on August 11, 2026
Key Terms
Rule 10b5-1, Non-Qualified Stock Option, Restricted Stock Unit, open market sale, +1 more
5 terms
Rule 10b5-1 regulatory
"trading plan adopted by the reporting person in accordance with Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) for Cognex common stock"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Restricted Stock Unit financial
"Restricted Stock Unit convertible into Cognex common stock at no exercise price"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
open market sale market
"shares were disposed of in an open market sale pursuant to a trading plan"
An open market sale is when a company or a shareholder sells shares through the regular stock market to any willing buyer, using ordinary exchange trading rather than private deals. It matters to investors because it increases the number of shares available and can push the price down or change ownership balance—think of it like someone putting extra items on a supermarket shelf for any shopper to buy, which can lower the item's price if supply suddenly grows.
trading plan regulatory
"stock option exercises were effected pursuant to a trading plan adopted by the reporting person"
A trading plan is a written set of rules an investor follows about what to buy or sell, when to enter and exit positions, and how much risk to accept—like a travel itinerary that maps the route, stops, and budget before a trip. It matters because it helps remove emotional decisions during market swings, enforces discipline, and makes performance easier to review and improve, reducing the chance of costly impulsive moves.
FAQ
What did COGNEX (CGNX) CEO Matthew Moschner report in this Form 4?
Matthew Moschner reported exercising 16,600 stock options and selling 24,962 shares of Cognex common stock on August 11, 2026, with transactions tied to a pre-arranged Rule 10b5-1 trading plan and multiple historical option grants.
Were the Cognex (CGNX) CEO’s trades made under a 10b5-1 plan?
Yes. Footnotes state the stock option exercises and related open-market sales were made pursuant to a trading plan adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, indicating these transactions were pre-arranged.
What stock options did the Cognex (CGNX) CEO exercise in this filing?
Moschner exercised options covering 16,600 shares of Cognex common stock, with exercise prices of $40.71, $42.84, $51.49, and $56.44 per share, from option grants originally dated between February 2018 and October 2018 and vesting over multiple years.
What equity awards does the Cognex (CGNX) CEO still hold after these trades?
The CEO continues to hold multiple non-qualified stock options and restricted stock units, including options over 279,070 shares at $27.99 and RSUs over 56,928 shares, with expiration or vesting dates running from 2027 through 2036.
Does this Cognex (CGNX) Form 4 show the CEO’s remaining common stock holdings?
The data details shares sold, options exercised, and remaining option and RSU positions, but it does not report a post-transaction total of the CEO’s directly held common stock shares, focusing instead on transactional and derivative-holding information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
